Rockefeller Capital Management L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,687,064
+31.8%
70,342
+24.4%
0.01%
+25.0%
Q2 2023$2,039,037
+146277.4%
56,530
+55.0%
0.01%
+33.3%
Q1 2023$1,393
-25.5%
36,482
+10.9%
0.01%
-33.3%
Q4 2022$1,871
-99.5%
32,883
+228.4%
0.01%
+350.0%
Q3 2022$395,000
-15.4%
10,014
-5.8%
0.00%0.0%
Q2 2022$467,000
+41.1%
10,627
+27.9%
0.00%0.0%
Q1 2022$331,000
-3.5%
8,307
-2.8%
0.00%0.0%
Q4 2021$343,000
+1.5%
8,549
+2.8%
0.00%0.0%
Q3 2021$338,000
+1200.0%
8,313
+1350.8%
0.00%
Q2 2021$26,000
+18.2%
573
+7.5%
0.00%
Q1 2021$22,000
+4.8%
533
+6.6%
0.00%
Q4 2020$21,000
+61.5%
5000.0%0.00%
Q3 2020$13,000
-92.0%
500
-91.8%
0.00%
-100.0%
Q2 2020$163,000
+24.4%
6,088
-16.7%
0.00%0.0%
Q1 2020$131,000
+1355.6%
7,305
+1361.0%
0.00%
Q4 2019$9,0005000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders